blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1169445

EP1169445 - HUMAN PROTEINS AND POLYNUCLEOTIDES ENCODING THEM [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.08.2008
Database last updated on 25.09.2024
Most recent event   Tooltip29.08.2008Application deemed to be withdrawnpublished on 01.10.2008  [2008/40]
Applicant(s)For all designated states
Curagen Corporation
11th floor, 555 Long Wharf Drive
New Haven, CT 06511 / US
[2002/02]
Inventor(s)01 / FERNANDEZ, Elma
77 Florence Road 2B
Branford, CT 06405 / US
02 / VERNET, Corine
4830 N.W. 43rd Street P 253
Gainesville, FL 32060 / US
03 / SHIMKETS, Richard
191 Leete Street
West Haven, CT 06516 / US
 [2002/02]
Representative(s)Naylor, Kathryn May, et al
Mathys & Squire LLP 120 Holborn London
EC1N 2SQ / GB
[2008/32]
Former [2005/41]Naylor, Kathryn May, et al
Mathys & Squire 120 Holborn
London EC1N 2SQ / GB
Former [2005/09]Taylor, Kathryn May
Mathys & Squire, 100 Gray's Inn Road
London WC1X 8AL / GB
Former [2004/47]Crump, Julian Richard John
Mintz Levin Cohn Ferris Glovsky and Popeo Intellectual Property LLP The Rectory 9, Ironmonger Lane
London EC2V 8EY / GB
Former [2002/02]Schlich, George William, et al
Mathys & Squire 100 Gray's Inn Road
London WC1X 8AL / GB
Application number, filing date00921910.607.04.2000
[2002/02]
WO2000US09392
Priority number, dateUS19990128514P09.04.1999         Original published format: US 128514 P
US20000186592P03.03.2000         Original published format: US 186592 P
US2000054451106.04.2000         Original published format: US 544511
[2002/02]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0061754
Date:19.10.2000
Language:EN
[2000/42]
Type: A2 Application without search report 
No.:EP1169445
Date:09.01.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 19.10.2000 takes the place of the publication of the European patent application.
[2002/02]
Search report(s)International search report - published on:EP31.05.2001
ClassificationIPC:C12N15/12, C12N15/24, C07K14/47, C07K14/705, C07K16/28, C07K16/18, C07K16/24, G01N33/68, C12Q1/68, A61K38/17, A61K38/20, A61K49/00, A61K31/70, A61K39/395
[2002/02]
CPC:
C07K14/47 (EP,US); A61P15/00 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P19/00 (EP);
A61P19/02 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P25/08 (EP); A61P25/18 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P31/00 (EP);
A61P35/00 (EP); A61P37/04 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P7/00 (EP);
A61P9/10 (EP); C07K14/54 (EP,US); C07K14/705 (EP,US);
C07K14/70571 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/02]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:MENSCHLICHE PROTEINE UND DAFÜR KODIERENDE POLYNUKLEOTIDE[2007/52]
English:HUMAN PROTEINS AND POLYNUCLEOTIDES ENCODING THEM[2002/02]
French:NOUVELLES PROTEINES HUMAINES ET POLYPEPTIDES CODANT POUR CES PROTEINES[2002/02]
Former [2002/02]MENSCHLICHE PROTEINS UND DAFÜR KODIERENDE POLYNUKLEOTIDE
Entry into regional phase05.11.2001National basic fee paid 
05.11.2001Designation fee(s) paid 
05.11.2001Examination fee paid 
Examination procedure09.11.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
05.11.2001Examination requested  [2002/02]
21.05.2003Despatch of a communication from the examining division (Time limit: M06)
27.11.2003Reply to a communication from the examining division
21.06.2004Despatch of a communication from the examining division (Time limit: M06)
29.12.2004Reply to a communication from the examining division
29.07.2005Despatch of a communication from the examining division (Time limit: M06)
08.02.2006Reply to a communication from the examining division
30.11.2007Communication of intention to grant the patent
11.04.2008Application deemed to be withdrawn, date of legal effect  [2008/40]
16.05.2008Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2008/40]
Fees paidRenewal fee
14.03.2002Renewal fee patent year 03
22.04.2003Renewal fee patent year 04
26.04.2004Renewal fee patent year 05
08.03.2005Renewal fee patent year 06
16.06.2006Renewal fee patent year 07
27.06.2007Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.04.200607   M06   Fee paid on   16.06.2006
30.04.200708   M06   Fee paid on   27.06.2007
30.04.200809   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DXA]WO9849310  (ZYMOGENETICS INC [US]) [DX] 59 * 90,55% identity in 180 aa overlap with seq ID no.2 (1-178:1-180) * * 97,48% identity in 714 nt overlap with seq ID no.1 (1-708:2-706) *; page 29 - page 33; claim - * * Sequences ID no.1 and no.2 pages 53-55 * [A] 5,13,14,17,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,54,56,59,61-63,65,67,69,71;
 [DXA]WO9903982  (HUMAN GENOME SCIENCES INC [US], et al) [DX] 59 * 90,56% identity in 180 aa overlap with seq ID no.2 (1-178:1-180) * * 99,85% identity in 694 nt overlap with seq ID no.1 (21-708:1-694) *;; figure 1; example -; claim - * [A] 5,13,14,17,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,54,56,58,61-63,65,67,69,71;
 [DXA]WO9630052  (UMDNJ NEW JERSEY S UNIVERSITY [US]) [DX] 59 * claim - * [A] ;
 [A]WO9845437  (GENETICS INST [US]) [A] 5,13,14,17,20 * 97,89% identity in 465nt overlap between seq ID no.21 and seq ID no.415 (533-997:17-481) * * sequence ID no.415 *;
 [XDA]WO9906552  (GENSET SA [FR], et al) [XD] 13 * 100% identity in 84 aa overlap with seq ID no.20 (1-84:1-84) * sequence ID no.404 page 374 * [A] 5,14;
 [A]WO9906548  (GENSET SA [FR], et al) [A] 5,13,14,17,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,54,56,58,59,61-63,65,67,69,71 * 99,5% identity in 435 nt overlap between seq ID.21 and no.40 (527-961:4-438) * * sequence ID no.40 page 30 * * abstract *;
 [DXA]WO9627603  (MILLENNIUM PHARM INC [US]) [DX] 59 * 97% identity in 137 aa overlap with seq ID no.22 and fig.24 (1-137:1-138) and 98% identity in 450nt overlap between seq ID 21 and fig.24 (548-997:3-452) *;; figures 17,24 * [A] 5,13,14,17,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,58,61-63,65,67,69,71;
 [PX]WO9963088  (GENENTECH INC [US], et al) [PX] 1-4,6,10-12,15,16,18,19,21-23 * fig.228 has 100% identity with the whole sequence ID no.26 and fig.227 has 99,72% identity in 1071 nt overlap with seq ID no.25 (29-1099:524-1593) * * 99,25% identity in 269 aa overlap with seq ID no.28(1-269:193-461) and 99,62% identity in 1054 nt overlap with seq ID no.27 (1-1054:540-1593) *;; figures 227,228 * * page 203, line 3 - page 205, line 4 *;
 [PX]WO0012708  (GENENTECH INC [US], et al) [PX] 5,13,14,17,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,54,56,58,59,61-63,65,67,69,71 * 100% identity between sequence ID no.20 and figure no.20 and 100% identity in 1208 nt overlap with seq ID no19 (1-1208:8-1215) *;; figures 19,20 * * example -; claim - * * page 56 - page 58 *;
 [PX]WO9958668  (ONO PHARMACEUTICAL CO [JP], et al) [PX] 5,13,14,17,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,54,56,58,59,61-63,65,67,69,71 * 99,7% identity in 344 aa overlap with seq ID no.6* * 99,9% identity in 1032 nt overlap with seq ID no.3 (92-1123:1-1032) * * 99,7% identity in 313 aa overlap with seq ID no.4 (1-344:1-344) * * Sequences ID no.1, 2, 5 and 6 *;
 [PA]WO9918126  (ONO PHARMACEUTICAL CO [JP], et al) [PA] 5,13,14,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,54,56,58,59,61-63,65,67,69,71 * 97% identity in 137 aa overlap between seq ID 22 and seq ID no.34 * * 98% identity in 463 nt overlap between seq ID no.21 and no.36 (535-997:1-463) * * sequence ID no.34 and no.36 *;
 [PA]WO9960127  (GENENTECH INC [US], et al) [PA] 5,13,14,17,20 * 98,46% identity in 716 nt overlap with seq ID no.1 (1-708:116-830) * * 90 identity with seq ID no.2 * * 99,12% identity in 686 nt overlap with seq ID no.1(24-703:1-686) * * figures 1,2,5 *;
 [DPX]WO9946281  (GENENTECH INC [US], et al) [DPX] 5,13,14,17,20 * fig.221 has 99,9% identity with seq ID no.3 in 1603 nt overlap (1-1603:43-1645) * *fig.197 has 99,125% identity in 686 nt overlap with seq ID 1 (24-703:1-686) * * fig.222 has 99,41% identity in 344 aa overlap with seq ID no.6 and no.4 (1-344:1-343) *;; figures 197,198,221,222 *;
 [DPA]WO9935267  (IMMUNEX CORP [US], et al) [DPA] 5,13,14,17,20 * 98,8% identity in 540 nt overlap with seq ID no.1 (65-598:1-540) and 90,56% identity in 180 aa overlap with seq ID no.2 1-178:1-180) * * sequences ID no1 and no.2; page 5 - page 7 *;
 [PDA]WO9932632  (MILLENNIUM BIOTHERAPEUTICS INC [US]) [PDA] 5,13,14,17,20,24-26,28,30,32,34,36,39,40,43,44,48,50,52,54,56,58,59,61-63,65,67,69,71 * 99% identity in 702 nt overlap with seq ID no.1 (14-708:17-718) *;; figure 1A *
 [A]  - M.D. ADAMS ET AL, "Use of human BAC end sequences for sequence-ready map building", EMBL, (19980930), XP002143978 [A] 10,11 * abstract *
    [ ] - UNPUBLISHED
 [DA]  - A.F. STRUYK ET AL, "Cloning of neurotrimin defines a new subfamily of differentially expressed neural cell adhesion molecules", EMBL, (19950419), XP002152432 [DA] 5,13,14,17,20 * abstract *
    [ ] - THE JOURNAL OF NEUROSCIENCE, (199503), vol. 15, no. 3, pages 2141 - 2156, XP000953464
 [A]  - H. SEHRA ET AL, "Human DNA sequence from clone 718J7 on chromosome 20q13.31-13.33. contains part of a gene for a novel protein , the PCK1 gene for soluble phosphoenolpyruvate carboxykinase 1", EMBL, (19990224), XP002152433 [A] 5,13,14,17,20 * abstract *
 [A]  - L.HILLIER ET AL, "zl881e02.r1 Stratagene colon (#937204) Homo sapiens cDNA clone IMAGE:511034 5', mRNA sequence", EMBL, (19961030), XP002152434 [A] 5,13,14,17,20 * abstract *
    [ ] - P. WOHLDMANN ET AL, "generation and analysis of 280,000 human expressed sequence tags", GENOME RESEARCH, (1996), vol. 6, no. 9, pages 807 - 828, XP000914615
 [AD]  - J.I. JONSSON, "Mus musculus mRNA for myeloid associated differentiation protein", EMBL, (19971001), XP002152435 [AD] 5,13,14,17,20 * abstract *
    [ ] - M. PETTERSSON ET AL, "Isolation of MYADM, a novel hematopoietic-associated marker gene expressed in multipotent progenitor cells and up-regulated during myeloid differentiation", JOURNAL OF LEUKOCYTE BIOLOGY, (2000), vol. 67, pages 423 - 431
 [PDA]  - O. OHARA ET AL, "Homos sapiens mRNA for KIAA1061 protein, partial cds", EMBL, (19990804), XP002152436 [PDA] 1-20 * abstract * * Q9UPU1: 100% identity in 693 aa overlap with seq ID no.16(150-842:1-693) * * 100% identity in 895 nt overlap with seq ID no.13 (221-1115:1-895) * * 100% identity in 4719 nt overlap with seq ID no.17 (784-5502:1-4719) * * 100% identity in 4719 nt overlap with seq ID no.15 (853-5571:1-4719) * * 100% identity in 693 aa overlap with seq ID no.18 (123-815:1-693) * * 100% identity in 298 aa overlap with seq ID no.14 (9-306:1-298) *
    [ ] - R. KIKUNO ET AL, "Prediction of the coding sequences of unidentified human genes.XIV. The complete sequence of 100 new cDNA clones from brain which code for large proteins in vitro", DNA RESEARCH, (1999), vol. 6, pages 197 - 205, XP000852618

DOI:   http://dx.doi.org/10.1093/dnares/6.3.197
 [PA]  - R.H. WATERSTON, "The sequence of Homo sapiens clone", EMBL, (20000111), XP002152437 [PA] 6,10-12,15,16,18,19 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.